Aim-To assess the value of detecting human papillomavirus (HPV) DNA in false negative archival cervical smears in population based screening programmes for cervical cancer. Methods-Cytomorphologically classified false negative archival Pap smears (n = 27) taken from 18 women up to six years before cervical cancer was diagnosed were blindly mixed with 89 smears from hospital patients with a variety of gynaecological complaints and tested for HPV by the polymerase chain reaction (PCR). Corresponding cervical cancer biopsy specimens were also available for HPV analysis. Neither the examining cytopathologist nor the molecular biologist was aware of the study design. Results-HPV DNA was detected in the smears of 16 patients with cervical cancer missed previously by cytology. HPV 16 and 18 were found predominantly in those smears taken up to six years before the diagnosis of cervical cancer. We have shown recently in a prospective study that only patients with cytomorphologically abnormal smears containing high risk HPV types are at high risk of developing progressive CIN. ' The aim of the present study was to determine whether HPV was present in 27 archival cervical smears taken up to six years before the women were diagnosed with cervical cancer.
In industrialised countries screening for cervical cancer is based on the presence of cytomorphologically abnormal epithelial cells in cervical smears. In spite of the success of cytomorphological examination in screening for cervical cancer, major drawbacks have been recognised.' The percentage of false negative smears varies considerably between 15% and 50%,2-5 while the number of false positive cervical smears is about 10%. Therefore, the sensitivity of cytology in screening for cervical cancer is quite low (50-85%) and the specificity is about 90%. This unreliability is compensated for clinically by repeating the procedure within a rather short time interval, up to three years,"8 depending on the results of the Pap smears. It has been shown recently that cervical cancer is strongly associated with the presence ofhigh risk or oncogenic human papillomavirus (HPV) types (up to 100%).910 In addition, a number of clinical follow up studies of women with cervical intraepithelial neoplasia (CIN) indicate that the presence of HPV DNA is of predictive value in progressive CIN disease."-"
We have shown recently in a prospective study that only patients with cytomorphologically abnormal smears containing high risk HPV types are at high risk of developing progressive CIN. ' The aim of the present study was to determine whether HPV was present in 27 archival cervical smears taken up to six years before the women were diagnosed with cervical cancer.
Methods

STUDY DESIGN
From 1982 to 1993 a triannual cervical cancer screening programme was conducted in the district of Het Gooi, an area near Amsterdam, The Netherlands. Cervical smears were taken by several general practitioners and gynaecologists. Routine This is largely thought to be because of population based cervical cancer screening programmes using Pap smears for the detection of cytomorphologically abnormal cells. [23] [24] [25] [26] However, the Pap smear has not eradicated the disease in any screened population to date. Reports on failures of cytology to predict cervical cancer and cumulative false negative error rates for invasive cancer of up to 50% have been published.27 This complex cervical cancer detection system is prone to errors both in sampling (sampling error) and cytomorphological interpretation by the cytologist (screening error).' Recent improve screening for cervical cancer. With this in mind, we designed this retrospective study. Although patients with true negative smears would comprise the most appropriate control group, the expected prevalence of cervical cancer within the short time span studied (seven years) following a negative smear is so low (3% in The Netherlands) that any epidemiological control group had to be very large to be informative. This was checked in a pilot study of 40 age matched patients with cytomorphologically confirmed true negative smears over seven years old. We only found one HPV 16 positive case and no abnormal cytology in the seven year follow up period (unpublished data).
HPV DNA was detected in the early smears of those women who subsequently developed cervical carcinoma. Interestingly, in one patient both smears were unsuitable for cytomorphological examination, indicating that testing for HPV can yield good results even in cytologically inadequate smears. Another important observation is that in the same patient the same HPV type was present in both the diagnostic biopsy specimen and the smears taken seven years before the diagnosis of cervical cancer. Moreover, if two smears were available, the same HPV type was found in both. By contrast, a variety of HPV types, which subsequently disappeared during follow up, were detected in the control group. These patients did not develop cervical cancer.
This fits the hypothesis that persistent infection with high risk HPV types is a prerequisite for the development of cervical cancer9" and suggests that the continuous detection of a high risk HPV type in cervical smears is a significant risk factor for the development of invasive cervical cancer. Indeed, we have recently shown, in a longitudinal, noninterventional, colposcopic study in 327 women presenting with abnormal cytology, that progression to cancer was only found in those women who had a persistent HPV infection. 5 34
Re-examination of smears taken from a woman who subsequently developed cervical cancer revealed that nearly all of the smears contained abnormal cells. Therefore, the detection of high risk HPV types, in conjunction with cytology, could potentially reduce the number of erroneously classified cervical smears substantially. Cytologically negative, HPV positive smears should be rescreened, thereby increasing the detection rate of abnormal cervical cells. For the Dutch population over 35 years of age, this means that 2% (the prevalence of high risk HPV types in this group) of cytomorphologically normal smears would be re-examined." In a preliminary experiment cytomorphologically abnormal cells were detected in smears from about 50% of women with normal cytology and oncogenic HPV types on rescreening (Meijer, personal communication).
As invasive cervical cancer takes about years to develop,"5 the screening interval for women with cytomorphologically normal, HPV negative smears aged over 35 years could be increased to more than three years,3637 as is presently the case in The Netherlands. In this way, more effective screening with fewer screening errors could be attained. Analyses of the cost of these alternative screening approaches are currently under way. This work was supported by grants from the Prevention Fund (28-1502.2) and the Dutch Cancer Society "Koningin Wilhelmina Fonds" IKA-VU-91-10, The Netherlands. PJF Snijders is a fellow of the Royal Netherlands Academy of Arts and Sciences. We are indebted to Sandra de Kruijf and Willemijn Lodder for excellent technical assistance and Drs P van Diest and P van der Valk for critical reading of the manuscript.
